De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: Results from an observational study

Intensive Care Medicine

Volumn 40, Issue 1, 2014, Pages 41-49

  Mokart, Djamel ^a   Slehofer, Géraldine ^b   Lambert, Jérôme ^c   Sannini, Antoine ^a   Chow Chine, Laurent ^a   Brun, Jean Paul ^a   Berger, Pierre ^a   Duran, Ségolène ^a   Faucher, Marion ^a   Blache, Jean Louis ^a   Saillard, Colombe ^a   Vey, Norbert ^a   Leone, Marc ^b  

^a INSTITUT PAOLI CALMETTES   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Antibiotics; De escalation; Neutropenia; Septic shock; Severe sepsis

Indexed keywords

AMINOGLYCOSIDE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BETA LACTAM; LINEZOLID; QUINOLONE DERIVATIVE; VANCOMYCIN;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NEUTROPENIA; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SEPTIC SHOCK; SHORT TERM SURVIVAL;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CANCER CARE FACILITIES; COMORBIDITY; FEMALE; FRANCE; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEPSIS; SURVIVAL ANALYSIS;

EID: 84891001182     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-013-3148-9     Document Type: Article

References (35)

1. Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165-228
2. Kollef MH, Micek ST (2005) Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Med 33:1845-1853
3. Shorr AF (2009) Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit. Crit Care Med 37:1463-1469
4. Leone M, Bourgoin A, Cambon S, Dubuc M, Albanese J, Martin C (2003) Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med 31:462-467
5. Leone M, Garcin F, Bouvenot J et al (2007) Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse. Crit Care Med 35:379-385
6. Rello J, Vidaur L, Sandiumenge A et al (2004) De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 32:2183-2190
7. Heenen S, Jacobs F, Vincent JL (2012) Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often? Crit Care Med 40:1404-1409
8. Talpaz M, Shah NP, Kantarjian H et al (2006) Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N Engl J Med 354:2531-2541
9. Vanneman M, Dranoff G (2012) Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer 12:237-251
10. Song JU, Suh GY, Park HY et al (2012) Early intervention on the outcomes in critically ill cancer patients admitted to intensive care units. Intensive Care Med 38:1505-1513
11. Legrand M, Max A, Schlemmer B, Azoulay E, Gachot B (2011) The strategy of antibiotic use in critically ill neutropenic patients. Ann Intensive Care 1:22
12. Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 52:427-431
13. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
14. Bernard GR, Artigas A, Brigham KL et al (1994) The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818-824
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) Prognosis in acute organ-system failure. Ann Surg 202:685-693
16. Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/north American multicenter study. JAMA 270:2957-2963
17. Vincent JL, de Mendonça A, Cantraine F et al (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 26:1793-1800
18. Azoulay E, Mokart D, Lambert J et al (2010) Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 182:1038-1046
19. Azoulay E, Schlemmer B (2006) Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 32:808-822
20. Meunier F, Lukan C (2008) The first European conference on infections in leukaemia - ECIL1: a current perspective. Eur J Cancer 44:2112-2117
21. Buchheidt D, Bohme A, Cornely OA et al (2003) Diagnosis and treatment of documented infections in neutropenic patients-recommendations of the infectious diseases working party (AGIHO) of the German society of hematology and oncology (DGHO). Ann Hematol 82(Suppl 2):S127-S132
22. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D (2003) Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115:529-535
23. Mikulska M, Akova M, Averbuch D, Klyasova G, Livemore D, Orasch C et al. 4th European Conference on Infections in Leukemia. http://www.ebmt.org/Contents/ Resources/Library/ECIL/Documents/ ECIL4%202011%20Bacterial%20resistance%20in%20Haematology.pdf. 14-2-2012
24. Trecarichi EM, Tumbarello M, Spanu T et al (2009) Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect 58:299-307
25. Tumbarello M, Spanu T, Sanguinetti M et al (2006) Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 50:498-504
26. Safdar A, Rolston KV (2007) Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 45:1602-1609
27. Kollef MH (2006) Providing appropriate antimicrobial therapy in the intensive care unit: surveillance vs. de-escalation. Crit Care Med 34:903-905
28. Morel J, Casoetto J, Jospe R et al (2010) De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit. Crit Care 14:R225
29. Karvunidis T, Chvojka J, Lysak D et al (2012) Septic shock and chemotherapy-induced cytopenia: effects on microcirculation. Intensive Care Med 38:1336-1344
30. Mokart D, van Craenenbroeck T, Lambert J et al (2012) Prognosis of acute respiratory distress syndrome in neutropenic cancer patients. Eur Respir J 40:169-176
31. Xu XJ, Tang YM, Liao C et al (2013) Inflammatory cytokine measurement quickly discriminates gram-negative from gram-positive bacteremia in pediatric hematology/oncology patients with septic shock. Intensive Care Med 39:319-326
32. Depuydt P, Benoit D, Vogelaers D et al (2006) Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures. Intensive Care Med 32:1773-1781
33. Azoulay E, Mokart D, Rabbat A et al (2008) Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med 36:100-107
34. Burghi G, Lemiale V, Seguin A et al (2011) Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis. Intensive Care Med 37:1605-1612
35. Silva BN, Andriolo RB, Atallah AN, Salomao R (2013) De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev 3:CD007934